NCT01868126View on ClinicalTrials.gov

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions

Open-angle Glaucoma or Ocular Hypertension

Interventions

DRUG

DE-117 ophthalmic solution

DRUG

latanoprost ophthalmic solution

OTHER

Placebo

Trial Locations (7)

14618

Rochester

30260

Morrow

44115

Cleveland

64133

Kansas City

78240

San Antonio

78731

Austin

92663

Newport Beach

All Listed Sponsors

lead

Santen Inc.

INDUSTRY

NCT01868126 - Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter